United States · FDA National Drug Code directory
Relistor
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65649-552_9db15b8c-2928-4b75-a33b-548416afc8c9
- Product NDC
- 65649-552
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Methylnaltrexone bromide
- Labeler
- Salix Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20080424
- Source listing expiry
- 20271231
Source-listed ingredients
- METHYLNALTREXONE BROMIDE — 8 mg/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 7 BLISTER PACK in 1 CARTON (65649-552-04) / 1 SYRINGE in 1 BLISTER PACK / .4 mL in 1 SYRINGE · 65649-552-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →